MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    The influence of Parkinson’s disease duration on perceived quality of inpatient care

    L. Eickholt, C. Kruse, W. Aamodt (Philadelphia, USA)

    Objective: There are currently no disease-modifying therapies for persons with Parkinson’s disease (PD), and progressive symptoms contribute to increased risk of hospitalization, particularly in the…
  • 2026 International Congress

    Handwriting Based Screening of Parkinson’s Disease Using Image Analysis of Drawing Tasks

    A. Shih, L. Cruz-Mondragon, V. Santini, S. Panchawagh (Winston-Salem, USA)

    Objective: To evaluate whether image-based analysis of handwriting drawing tasks can distinguish Parkinson's disease from healthy controls. Background: Fine motor impairment is a core feature…
  • 2026 International Congress

    Evidence of Systemic and Neuro-Inflammation in Progressive Supranuclear Palsy: Insight from an Imaging-Inflammation Study

    S. Dey, A. Kumar, K. Paranthaman, S. Mondal, P. Kumar, P. Pal, R. Yadav, M. Debnath (Bengaluru, India)

    Objective: To investigate the role of Th17 pathway in systemic and central inflammation in PSP and to identify signatures of inflammation-induced neurodegeneration in PSP. Background:…
  • 2026 International Congress

    Grip strength and hand distress in de novo Parkinson´s disease: support for early rehabilitation

    A. Szymanska, E. Franzén, L. Dahlin, S. Grigoriou, B. Lindholm (Malmö, Sweden)

    Objective: To describe grip strength and upper limb (UL) distress in de novo PD, and to explore associations with motor symptoms. Background: Grip strength is…
  • 2026 International Congress

    Incidence and movement disorders associated with Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT) in the Princess Maha Chakri Sirindhorn Medical Center (MSMC)

    K. Methawasin, N. Suthumchai, N. Wangwiwatcharoen, K. Anuroj (Nakhon Nayok, Thailand)

    Objective: To identify incidence and clinical features of SREAT patients in MSMC. Background: SREAT patients could present with encephalopathy with various neurological abnormalities, including behavioral…
  • 2026 International Congress

    A Longitudinal Case of Adult-Onset Progressive Ataxia in a Patient with a Pathogenic Variant of IRF2BPL

    S. de Groot, W. Rai (Sioux Falls, USA)

    Objective: To describe the course of a patient with an inherited IRF2BPL variant presenting as adult-onset indolent ataxia and tremor with no prior developmental abnormalities,…
  • 2026 International Congress

    Unnecessary Ablative Surgery in an Untreated Parkinson’s Disease Patient: Marked Clinical Improvement After Initiation of Dopaminergic Therapy

    B. Mukhammedaminov, N. Aripova, Y. Nishonova (Tashkent, Uzbekistan)

    Objective: To report a case of Parkinson’s disease (PD) in which two ablative procedures were performed without prior dopaminergic therapy, followed by significant clinical improvement…
  • 2026 International Congress

    Irisin as a Molecular Mediator of Exercise Induced Neuroprotection and Disease Modification in Parkinson’s Disease

    NIK. Choudhary (Jodhpur, India)

    Objective: To integrate mechanistic evidence delineating irisin mediated molecular pathways relevant to Parkinson’s disease (PD) pathogenesis and neuroprotection, focusing on α-syn clearance, autophagy–lysosomal function, mitochondrial…
  • 2026 International Congress

    Cross-Cultural Validation of the Hebrew version of The International Parkinson and Movement Disorder Society Non-Motor Rating Scale

    VL. Livneh, A. Ezra, H. Lentschitzky, A. Socher, A. Thaler, A. Hilel, H. Shabtai, J. Zitser, G. Eshed, T. Shainer, P. Ponger, R. Alcalay, Y. Manor, V. Rozani, S. Luo, C. Goetz, G. Stebbins, P. Martin, T. Mestre, A. Ferro (Tel Aviv, Israel)

    Objective: This study aims to validate the Hebrew version of the MDS-NMS and make it suitable for use in Hebrew speaking population Background: Parkinson's disease is a complex neurodegenerative disease with…
  • 2026 International Congress

    Comparative efficacy and safety of Safinamide versus Opicapone in Japanese patients with Parkinson’s Disease and wearing-off: A matching-adjusted indirect comparison

    N. Nishikawa, R. Ando, T. Ishida, T. Hatano, N. Hattori, M. Nomoto (Tokyo, Japan)

    Objective: To compare efficacy and safety outcomes with safinamide and opicapone as adjuncts to levodopa in Parkinson’s disease (PD) patients with wearing-off using an anchored…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley